GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipum AB (OSTO:LIPUM) » Definitions » Other Long Term Assets

Lipum AB (OSTO:LIPUM) Other Long Term Assets : kr-0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Lipum AB Other Long Term Assets?

Lipum AB's other long-term assets for the quarter that ended in Dec. 2023 was kr-0.00 Mil.

Lipum AB's quarterly other long-term assets increased from Mar. 2023 (kr-0.00 Mil) to Sep. 2023 (kr-0.00 Mil) but then stayed the same from Sep. 2023 (kr-0.00 Mil) to Dec. 2023 (kr-0.00 Mil).

Lipum AB's annual other long-term assets declined from Dec. 2021 (kr1.56 Mil) to Dec. 2022 (kr-0.00 Mil) and declined from Dec. 2022 (kr-0.00 Mil) to Dec. 2023 (kr-0.00 Mil).


Lipum AB Other Long Term Assets Historical Data

The historical data trend for Lipum AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipum AB Other Long Term Assets Chart

Lipum AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
- 1.05 1.56 - -

Lipum AB Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.94 - - - -

Lipum AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Lipum AB (OSTO:LIPUM) Business Description

Traded in Other Exchanges
N/A
Address
Tvistevagen 48 C, Umea, SWE, 907 36
Lipum AB is a clinical-stage biopharmaceutical company specializing in the discovery and development of a novel treatment for chronic inflammatory diseases. The candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule (BSSL) of the immune system. The development is supported by solid pre-clinical data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need.

Lipum AB (OSTO:LIPUM) Headlines

No Headlines